Sichuan Tong Yuan Pharmaceutical Co., Ltd. is formal. Sichuan Tong Yuan Pharmaceutical Co., Ltd. was approved by the relevant departments of industry and commerce, medicine and so on, and applied for a patent. Tong Yuan Pharmaceutical Co., Ltd. was established in 1992, which is a high-tech pharmaceutical enterprise mainly producing modern Chinese medicine and characteristic western medicine. After 18 years of rapid development, it now has five wholly-owned and holding subsidiaries: Sichuan Tong Yuan Pharmaceutical Co., Ltd., Shaanxi Tong Yuan Pharmaceutical Co., Ltd., Tong Yuan New Drug R&D Center, Sichuan Tong Yuan Health Food Co., Ltd., Sichuan Shu Wei Pharmaceutical Co., Ltd. and * * *. It has formed a modern enterprise integrating R&D, production and sales with modern Chinese medicine, chemical medicine, raw material medicine and nutrition and health care products. Sichuan Tong Yuan Pharmaceutical Co., Ltd. was established in 1992, covering an area of 120 mu. It was designed and built in strict accordance with GMP requirements, with a building area of 26,000 square meters and a clean area of 15000 square meters. The number of employees exceeds 1000, and the proportion of professional and technical personnel exceeds 30%; More than 62 drugs have been approved by the US Food and Drug Administration. The company has a reasonable variety structure and a smooth sales network. At present, it has four sales teams, including clinical, OTC, generic drugs and the third terminal. It has been engaged in pharmaceutical sales management for more than 10 years, and has 22 sales branches in China with more than 1000 customers. It has more than 30 national medical insurance products and 2 traditional Chinese medicine products, and the main product is fresh bamboo juice, which accounts for half of similar products. Tong Yuan New Drug R&D Center was established in 2008. With dozens of high-quality professional researchers, we have long-term cooperation with Sichuan Institute of Antibiotics, West China University of Medical Sciences and other universities and medical research institutes to undertake new drug research, new drug imitation, patent application and clinical experiments for the future development of Tong Yuan pharmaceutical industry. At present, the research focus of R&D Center is dermatology, pediatric new drugs and new antibiotics, and more than 5 SFDA clinical studies or imitation new drugs are reported every year.